Massive Bio is a marketplace that connects cancer patients and their treating oncologists to clinical trials and advanced care plans while enabling enterprises to get access to patients at community practices to enhance oncology research. Massive Bio provides virtual tumor board, clinical trial services (patient identification, pre-screening, site selection) and real-world evidence services. Massive Bio’s enterprise customers are Contract Research Organizations (CROs), pharmaceutical companies, diagnostics labs and providers. Massive Bio combines patient acquisition, Artificial Intelligence (AI) based scalable pre-screening, operationalization support and real world data to connect patients to oncology trials.